Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS-Reference-Cited by-同舟云学术

Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS

Published:2001-01 Issue:1-2 Volume:112 Page:139-145
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Waubant E,Gee L,Bacchetti P,Sloan R,Cotleur A,Rudick R,Goodkin D

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference27 articles.

1. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis;Correale;J. Immunol.,1995

2. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapses;Gayo;J. Neuroimmunol.,1998

3. Longitudinal study of soluble adhesion molecules in multiple sclerosis: Correlation with gadolinium enhanced magnetic resonance imaging;Giovannoni;Neurology,1997

4. A serial study of new multiple sclerosis lesions and white matter from which they arise;Goodkin;Neurology,1998

5. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging;Hartung;Ann. Neurol.,1995

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis;Frontiers in Molecular Neuroscience;2024-08-07

2. Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients;Frontiers in Neurology;2024-02-23

3. Under the influence: environmental factors as modulators of neuroinflammation through the IL-10/IL-10R axis;Frontiers in Immunology;2023-08-03

4. Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity;Biomedicines;2022-08-23

5. Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity;MedComm;2022-04-21